BIP_CREST II Registry

The CREST-2 Registry

The objective of C2R is to promote the rapid initiation and completion of enrollment in the CREST-2 randomized clinical trial (clinicaltrials.gov ID NCT02089217). Patients with severe symptomatic and asymptomatic carotid artery occlusive disease will be treated with carotid artery stenting (CAS) performed by experienced and skilled interventionists.

Key Eligibilities:
-Patients aged 18 - 80 years old with symptomatic or asymptomatic carotid artery disease.

Exclusion Criteria:
-Patients with any one of the following conditions are ineligible for enrollment in C2R: NYHA Class IV congestive heart failure, COPD on chronic continuous oxygen therapy, severe (Class Childs D) liver failure, end-stage renal failure requiring dialysis, cancer with metastatic spread and/or undergoing active chemotherapeutic treatment, any dementia considered greater than 'mild.'

**Other protocol-defined inclusion/exclusion criteria may apply. Please click on the NCT Number (below) to learn more about the study at clinicaltrials.gov.**
N/A
NCT02240862
Neurosciences
Stroke
Ethan Korngold MD
University of Maryland-Baltimore
Emily Johnson
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center